MHC class I down regulation, tumour escape from immune surveillance and design of therapeutic strategies.
Bubeník
J
J
D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D002471:Cell Transformation, Neoplastic / Q000235:genetics / Q000276:immunology*; D015536:Down-Regulation / Q000235:genetics / Q000276:immunology*; D015316:Genetic Therapy / Q000592:standards / Q000639:trends; D015395:Histocompatibility Antigens Class I / Q000276:immunology* / Q000378:metabolism; D006801:Humans; D007157:Immunologic Surveillance / Q000235:genetics / Q000276:immunology*; D007167:Immunotherapy / Q000592:standards / Q000639:trends; D007371:Interferon-gamma / Q000276:immunology; D009369:Neoplasms / Q000188:drug therapy / Q000235:genetics / Q000276:immunology*; D019139:Tumor Escape / Q000235:genetics / Q000276:immunology*
D015395:Histocompatibility Antigens Class I; D007371:Interferon-gamma